Literature DB >> 18566752

Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression.

Hamid Zand1, Ali Rahimipour, Saideh Salimi, Sayed Mohammad Shafiee.   

Abstract

Gamma-irradiation (Gamma-IR) resistance is a character of many malignant cells that decreases the efficacy of radiotherapy. Although ionizing radiation activates multiple cellular factors that vary depending on dose and tissue specificity, the activation of nuclear factor-kappa B appears to be a well-conserved response in tumor cells exposed to Gamma-IR which can lead to the inhibition of radiation-induced apoptosis. Thus, inhibition of NF-kappaB activation is an important strategy to abolish radioresistance. Recently, we have demonstrated that docosahexaenoic acid (DHA; 22:6 n-3 polyunsaturated fatty acids)-induced apoptosis may occur via ligand-dependent transcription factor, peroxisome proliferator-activated receptors-gamma. Moreover, many reports described that activation of PPAR-gamma can lead to the induction of apoptosis through NF-kappaB inhibition. Therefore, we addressed the mechanism that NF-kappaB is a downstream target of DHA and may be involved in the process of radiosensitization. Ramos cells are a highly radiation-resistant and p53-deficient Burkitt's lymphoma cell line. The results of present study showed that cotreatment of Ramos cells with low doses of DHA and Gamma-IR leads to marked phosphorylation of IkappaB and translocation of p65/NF-kappaB to nucleus in parallel with increase in apoptosis. Preincubation of the cells with GW9662, a selective antagonist for PPAR-gamma, significantly prevented NF-kappaB activation profile. Taken together, these results suggest that low concentration of DHA inhibited Gamma-IR-induced activation of NF-kappaB and sensitized Ramos cells to IR-induced cytotoxicity. Pretreatment of Ramos cells with GW9662 abrogated the ability of DHA to inhibit Gamma-IR-induced activation of NF-kappaB and diminished the DHA radiosensitizing effect indicating that PPAR-gamma may act as a mediator of DHA in inhibition of NF-kappaB. Taken together, these results suggest that low concentration of DHA inhibited Gamma-IR-induced activation of NF-kappaB and sensitized Ramos cells to IR-induced cytotoxicity. Pretreatment of Ramos cells with GW9662 abrogated the ability of DHA to inhibit Gamma-IR-induced activation of NF-kappaB and diminished the DHA radiosensitizing effect indicating that PPAR-gamma may act as a mediator of DHA in inhibition of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566752     DOI: 10.1007/s11010-008-9838-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  NF-kappaB signaling pathways in mammalian and insect innate immunity.

Authors:  N Silverman; T Maniatis
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

Review 3.  Dissecting p53-dependent apoptosis.

Authors:  J E Chipuk; D R Green
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 4.  Nuclear receptors and lipid physiology: opening the X-files.

Authors:  A Chawla; J J Repa; R M Evans; D J Mangelsdorf
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.

Authors:  Jinyang Yuan; Atsushi Takahashi; Naoya Masumori; Kohsuke Uchida; Shin-Ichi Hisasue; Hiroshi Kitamura; Naoki Itoh; Taiji Tsukamoto
Journal:  Urology       Date:  2005-03       Impact factor: 2.649

6.  Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.

Authors:  Magnus Lindskog; Helena Gleissman; Frida Ponthan; Juan Castro; Per Kogner; John Inge Johnsen
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

7.  Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells.

Authors:  N Yamagishi; J Miyakoshi; H Takebe
Journal:  Int J Radiat Biol       Date:  1997-08       Impact factor: 2.694

8.  Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.

Authors:  Victoria J Weston; Belinda Austen; Wenbin Wei; Eliot Marston; Azra Alvi; Sarah Lawson; Philip J Darbyshire; Mike Griffiths; Frank Hill; Jill R Mann; Paul A H Moss; A Malcolm R Taylor; Tatjana Stankovic
Journal:  Blood       Date:  2004-05-13       Impact factor: 22.113

9.  Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.

Authors:  Gabriella Calviello; Fiorella Di Nicuolo; Simona Serini; Elisabetta Piccioni; Alma Boninsegna; Nicola Maggiano; Franco O Ranelletti; Paola Palozza
Journal:  Cancer Chemother Pharmacol       Date:  2004-09-10       Impact factor: 3.333

10.  Early response gene signalling cascades activated by ionising radiation in primary human B cells.

Authors:  R E Wilson; S L Taylor; G T Atherton; D Johnston; C M Waters; J D Norton
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

View more
  13 in total

Review 1.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

2.  Chemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiber.

Authors:  Karen Triff; Eunjoo Kim; Robert S Chapkin
Journal:  Curr Pharmacol Rep       Date:  2015-02

3.  PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.

Authors:  Xianghuai Lu; Tamara C Murphy; Mark S Nanes; C Michael Hart
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-09       Impact factor: 5.464

Review 4.  Targeting inflammatory pathways for tumor radiosensitization.

Authors:  Amit Deorukhkar; Sunil Krishnan
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

5.  Rheinic acid ameliorates radiation-induced acute enteritis in rats through PPAR-γ/NF-κB.

Authors:  Haixia Sha; Yu Gu; Weixing Shen; Li Zhang; Fei Qian; Yudong Zhao; Haixiao Li; Ting Zhang; Weimin Lu
Journal:  Genes Genomics       Date:  2019-04-29       Impact factor: 1.839

6.  IUGR decreases PPARγ and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementation.

Authors:  Lisa A Joss-Moore; Yan Wang; Michelle L Baack; Jianrong Yao; Andrew W Norris; Xing Yu; Christopher W Callaway; Robert A McKnight; Kurt H Albertine; Robert H Lane
Journal:  Early Hum Dev       Date:  2010-09-24       Impact factor: 2.079

7.  Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure.

Authors:  Yang Yu; Zhi-Hua Zhang; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2011-11-14       Impact factor: 10.190

Review 8.  NF-kappaB and cancer: how intimate is this relationship.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bharat B Aggarwal
Journal:  Mol Cell Biochem       Date:  2009-10-08       Impact factor: 3.396

Review 9.  Dendritic cells and adipose tissue.

Authors:  Sandeep Sundara Rajan; Maria Paula Longhi
Journal:  Immunology       Date:  2016-08-23       Impact factor: 7.397

10.  Troglitazone reverses the multiple drug resistance phenotype in cancer cells.

Authors:  Gerald F Davies; Bernhard H J Juurlink; Troy A A Harkness
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.